• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
News and impact
NIHR Biomedical Research Centre Leicester

NIHR Biomedical Research Centre Leicester

  • Home
  • About Us
    • Leadership Team
    • Our Impact
    • Our NIHR infrastructure
    • Governance
    • Inclusion
    • Strategies
    • Contact us
  • Our Research
    • Our Impact
    • Spotlight on our researchers
    • Cardiovascular
    • Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health
    • Environment
    • Lifestyle
    • Personalised Cancer Prevention and Treatment
    • Respiratory and Infection
  • Patients and Public
    • Get Involved
    • Upcoming Public Involvement opportunities
    • Our approach to Public Involvement
    • Join the BioResource and Be Part of Research
    • Taking part in Clinical Trials
  • Industry and Partners
    • What we offer to industry
    • Collaborate with the Leicester BRC
    • Our partnerships
      • The NIHR Diet and Activity Research Translation (DART) Collaboration
  • For Researchers
    • Training
    • The Internal Resource Hub
    • Acknowledging and communicating your research
    • Guidance on Public Involvement (PPIE) for researchers
    • Advancing inclusion: transforming research culture in Leicester and beyond
    • PPI for Statistical Methodology and Research Techniques
  • News and Impact

Artificial Intelligence tool successfully predicts fatal heart rhythm

Mar 28, 2024

In a Leicester study that looked at whether artificial intelligence (AI) can be used to predict whether a person was at risk of a lethal heart rhythm, an AI tool correctly identified the condition 80 per cent of the time.

Dr Joseph Barker and Dr Xin Li

The findings of the study, led by Dr Joseph Barker working with Professor Andre Ng, Professor of Cardiac Electrophysiology and Head of Department of Cardiovascular Sciences at the University of Leicester and Consultant Cardiologist at the University Hospitals of Leicester NHS Trust, have been published in the European Heart Journal – Digital Health.  

Ventricular arrhythmia (VA) is a heart rhythm disturbance originating from the bottom chambers (ventricles) where the heart beats so fast that blood pressure drops which can rapidly lead to loss of consciousness and sudden death if not treated immediately.  

NIHR Academic Clinical Fellow Dr Joseph Barker coordinated the multicentre study at the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre,  and co-developed an AI tool with Dr Xin Li, Lecturer in Biomedical Engineering. The tool examined Holter electrocardiograms (ECGs) of 270 adults taken during their normal daily routine at home.    

These adults had the Holter ECGs taken as part of their NHS care between 2014 and 2022. Outcomes for these patients were known, and 159 had sadly experienced lethal ventricular arrhythmias, on average 1.6 years following the ECG.  

The AI tool, VA-ResNet-50, was used to retrospectively examine ‘normal for patient’ heart rhythms to see if their heart was capable of the lethal arrythmias.

Professor Ng said: “Current clinical guidelines that help us to decide which patients are most at risk of going on to experience ventricular arrhythmia, and who would most benefit from the life-saving treatment with an implantable cardioverter defibrillator are insufficiently accurate, leading to a significant number of deaths from the condition.

“Ventricular arrhythmia is rare relative to the population it can affect, and in this study we collated the largest Holter ECG dataset associated with longer term VA outcomes.  

“We found the AI tool performed well compared with current medical guidelines, and correctly predicted which patient’s heart was capable of ventricular arrhythmia in 4 out of every 5 cases.

“If the tool said a person was at risk, the risk of lethal event was three times higher than normal adults.

“These findings suggest that using artificial intelligence to look at patients’ electrocardiograms while in normal cardiac rhythm offers a novel lens through which we can determine their risk, and suggest appropriate treatment; ultimately saving lives.”

He added: “This is important work, which wouldn’t have been possible without an exceptional team in Dr Barker and Dr Xin Li, and their belief and dedication to novel methods of analysis of historically disregarded data.”

Dr Barker’s work has been recognised with a van Geest Foundation Award and Heart Rhythm Society Scholarship and more research will be carried out to develop the work further.

For the full paper, please visit   Artificial intelligence for ventricular arrhythmia capability using ambulatory electrocardiograms | European Heart Journal – Digital Health | Oxford Academic (oup.com)

For more on the work of the Cardiovascular theme, please click here.

Category: Press ReleasesTag: AI, artificial intelligence, cardiovascular, cardiovascular research, News, Press Release, ventricular arrythmia

Sidebar

Recent News

Leicester health specialists receive NIHR prizes for excelling in their fields

Respiratory researcher awarded Asthma + Lung UK Junior Fellowship

Weight-loss drug users turn to social media over doctors for advice

Read more news stories

The NIHR Leicester BRC is part of the NIHR and hosted by the University Hospitals of Leicester NHS Trust in partnership with the University of Leicester,  Loughborough University and the University Hospitals of the Northamptonshire NHS Group.

Get in touch

NIHR Leicester Biomedical Research Centre

University Hospitals of Leicester NHS Trust
Research & Innovation
Leicester General Hospital
Gwendolen Road
Leicester, LE5 4PW

Contact us

Our Research

Spotlight on our researchers

Cardiovascular

Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health

Environment

Personalised Cancer Prevention and Treatment

Lifestyle

Respiratory and Infection

About BRC

Our NIHR infrastructure

BRC clinical research during COVID-19

Our 2022 – 2028 strategy documents

Governance

Useful links

Our partnerships

Inclusion

Privacy notice

Cookie Policy

Copyright © NIHR Biomedical Research Centre: Leicester

  • LinkedIn
  • X
  • Facebook
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}